HomeStyles-Adults of Chinese Heritage
Launched by RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY · Nov 13, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The HomeStyles-Adults of Chinese Heritage trial is studying how a specific program can help improve the health of adults of Chinese heritage living in the United States. This group is facing increased risks for conditions like obesity and type 2 diabetes due to various lifestyle and environmental factors. The trial aims to see if a culturally tailored version of the HomeStyles program, which encourages a healthier diet and lifestyle, can lead to better health outcomes, such as improved diet, increased physical activity, and reduced inflammation in the body.
To participate in this study, you need to be an adult of Chinese heritage over 30 years old who either has a cardiometabolic condition (like diabetes or high blood pressure) or lives with someone who does. You should be the main person in your household making food decisions, have regular internet access, and be able to read English or Chinese. If you join, you’ll take part in a 10-week program where you’ll learn about healthy eating and lifestyle choices, and you may help researchers understand how these changes affect your health. Importantly, this study is not yet recruiting participants, but it aims to address the unique health needs of the Chinese community in the U.S.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult of Chinese heritage \>30 years with a self-reported cardiometabolic condition or living with an adult (spouse/partner, parent) with a cardiometabolic condition; primary food gatekeeper in the household (i.e., makes all or most decisions related to family food choices); has regular Internet access, read English and/or Chinese, and resides in New York/New Jersey metro area
- Exclusion Criteria:
- • Does not fit inclusion criteria
About Rutgers, The State University Of New Jersey
Rutgers, The State University of New Jersey, is a prestigious public research university renowned for its commitment to advancing medical science and public health. As a leading clinical trial sponsor, Rutgers leverages its extensive academic resources, cutting-edge facilities, and a diverse team of experts to conduct innovative research that addresses critical health challenges. The university fosters collaboration across disciplines, engaging in partnerships with healthcare institutions and industry leaders to enhance the development of novel therapies and improve patient outcomes. With a strong emphasis on ethical standards and regulatory compliance, Rutgers is dedicated to advancing clinical knowledge while prioritizing participant safety and well-being in all of its research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Carol Byrd-Bredbenner
Principal Investigator
Rutgers University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported